Entering into the Affordable Care Act health insurance marketplaces was a bad decision, according to the CEO of UnitedHealth Group Inc, which is considering pulling back from participation in 2017.
Entering into the Affordable Care Act (ACA) health insurance marketplaces was a bad decision for UnitedHealth Group Inc, according to its CEO.
Bloomberg Business reported that Stephen Hemsley told investors at a meeting in New York, that the company should have stayed out of the marketplaces longer. On November 19, the company announced that it was taking heavy losses as a result of its marketplace involvement and that it was considering no longer selling plans through the ACA in 2017.
“It was for us a bad decision,” Hemsley said, adding, “In retrospect, we should have stayed out longer.”
There are approximately 500,000 UnitedHealth customers on the exchanges. Other insurers have noted weak enrollment, which will take a toll on their profits, reported Reuters, but so far UnitedHealth is the only company to announce it may depart from the exchanges as a result.
As Hemsley explained during the investors meeting, the company will analyze during 2016 the products it offers and regions where it sells plans to determine where it could exit.
However, Hemsley did acknowledge that the problems were not necessarily a result of the exchanges and could be a UnitedHealth issue. Reuters further reported that a pullback from the exchanges could only be temporary, which wouldn’t be unheard of from the company, which also withdrew from Medicare Advantage and Medicaid before re-entering them later.
Dr Dalia Rotstein: Physicians Must Be Aware MS Affects People of All Backgrounds
April 24th 2024Dalia Rotstein, MD, MPH, emphazises the importance of awareness that multiple sclerosis (MS) impacts patients from various backgrounds as clinicians think through ways to improve access to care and research efforts in MS.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Polatuzumab Vedotin and R-CHP Appropriate for Untreated DLBCL
April 24th 2024Population pharmacokinetic and exposure-response analyses revealed a favorable benefit-risk profilane for the treatment combination of polatuzumab vedotin and rituximab, cyclophosphamide, doxorubicin, and prednisone (R-CHP).
Read More
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
Award-Winning Poster Presentations From AMCP 2024
April 23rd 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, multiple poster presentations concerned with health equity, data collection, glucagon-like peptide-1 agonists, and more were acknowledged for their originality, relevance, clarity, bias, and quality.
Read More